Interestingly, in a xenograft model of ER(+)/HER2 overexpressing breast cancer, the loss of the ER protein and deregulation of the progesterone receptor with increased mucins, especially MUC4, which has been associated with endocrine resistance in breast cancer, has been observed [108]. The gene discussed is MUC4; the disease is breast cancer.